Consumer Perceptions and Attitudes towards EDCs and PPCPs in Drinking Water
King's College London
Gabriella Rundblad (project manager and primary investigator)
Washington Metropolitan Council of Governments
February 2011 - October 2013
US and UK drinking water utilities are charged with providing safe drinking water to their customers, under the Safe Drinking Water Act, and the Water Act 2003 and the Water Industry Act 1999, respectively. Advances in research have yielded new and more precise analytical methods that allow water utilities to detect minute traces of emerging contaminants, such as endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in treated water. Recent reviews show that there is no significant risk to health associated with intake of EDCs or PPCPs via US or UK drinking water. However, there is also international evidence of hot-spots where the surface, ground, and drinking water is contaminated by pharmaceuticals, such as ciprofloxacin and cetirizine, and where public health may be compromised. Currently, neither the US nor the UK regulate EDCs or PPCPs, nor are any rules forthcoming in the foreseeable future, and the WHO does not provide any guidance either on this issue.
We have presented the results from this study at the 4th UK Cognitive Linguistics COnference, London 2012, the Health Protection Conference, Warwick 2012, the Applied Linguistics Association New Zealand Conference, Hamilton 2012, the Annual Conference and Exhibition, Denver 2013, the Public Health Science Conference, London 2013, the Metaphor and Health Communication Workshop, Lancaster 2014, and the Water Quality Technical Conference, New Orleans 2014.
UK WORKSHOP - 13 SEPTEMBER 2013:
The research team organised a water industry workshop in collaboration with the Drinking Water Inspectorate: Water and Contamination Workshop.
FINAL PROJECT REPORT: